Patient and Donor Intestinal Microbiota-Mucosal Immune Responses in Fecal Microbiota Transplantation with Alginate for Ulcerative Colitis

Patient and Donor Intestinal Microbiota-Mucosal Immune Responses in Fecal Microbiota Transplantation with Alginate for Ulcerative Colitis - Additional Considerations in Alginate Combined with Fecal Microbiota Transplantation for UC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056366

Enrollment

Registered

2024-12-06

Start date

2024-10-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: None

Exclusion criteria

Exclusion criteria: (1) Those who refused to participate in this study by opting out (2) Those deemed inappropriate as research subjects by the principal investigation

Design outcomes

Primary

Measure	Time frame
Using the gut bacterial community structure of each patient and their donor who achieved a therapeutic response, we will explore the effects of alginate add-on and its factors.	—

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo University Hospital Department of Gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results